Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SAN FRANCISCO — A federal judge ruled Wednesday that Walgreens can be held responsible for contributing to San Francisco's opioid crisis for over-dispensing opioids for years without proper oversight and failing to identify and report suspicious orders as required by law.

Walgreens contributed to San Francisco's opioid crisis, judge rules

Walgreens Boots Alliance contributed to the opioid epidemic in San Francisco through its sale of prescription drugs in the city, a federal judge concluded on Wednesday.

Walgreens prescriptions contributed to opioid epidemic in San Francisco - U.S. court

CVS Health

In this article will analyze the current, and future, outlook for CVS and WBA stocks and explain why each has a case to make for different investors.

CVS and Walgreens Show Why Investment Objectives Matter

AbbVie

Amcor Plc

Air Products and Chemicals

Franklin Resources

Caterpillar

Cincinnati Financial

Chevron

Federal Realty Investment Trust

Leggett & Platt

Medtronic

Realty Income Corp

Stanley Black & Decker

V.F.

Exxon Mobil

"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. 65 Aristocrats screened as of August 4, 2022 represented all eleven Morningstar Sectors. Broker estimated top-ten net gains ranged 14.54%-40.69% topped by XOM & SWK.

Buy 4 S&P 500 August Dog Days Dividend Aristocrats

An ambitious growth plan adds to its positive outlook.

1 Absurdly Cheap High-Yield Dividend Stock I Just Bought

Intuitive Surgical

Johnson & Johnson

As a whole, healthcare has done better than the broader market this year.

2 Trends That Suggest Healthcare Stocks Can Beat the Bear Market

The state of Tennessee sued Walgreens on Wednesday, accusing the retail pharmacy giant of fueling the state's opioid epidemic by willfully flooding the market with an oversupply of prescription narcotics in violation of consumer protection and public nuisance laws.

Tennessee sues Walgreens pharmacy chain over opioid distribution

Walgreens Boots Alliance reported mediocre third quarter results but is maintaining its full year guidance. The company is not only recession-proof but also trading for an extremely low valuation multiple, which could make it a good investment in the coming quarters.

Making Your Portfolio Recession-Proof: Walgreens Boots Alliance

Home Depot

Are these dow jones industrial average stocks on your August 2022 watch list?

3 Dow Jones Industrial Average Stocks For Your August 2022 Watchlist

Kimberly-Clark

For every pack of Huggies ® Diapers purchased at a Walgreens store or online at Walgreens.com this August, Huggies® will donate a day's worth of diapers to the National Diaper Bank Network, up to 1 million diapers. NEENAH, Wis.

HUGGIES® AND WALGREENS® ENCOURAGE PARENTS TO JOIN THEM IN SUPPORTING FAMILIES STRUGGLING WITH DIAPER NEED

Walgreens is looking to diversify its business model and achieve growth. The company is making progress towards distribution efficiency and is seeing promising growth in its online and primary care offerings.

Walgreens Has Gotten Way Too Cheap

T. Rowe Price Group

Whirlpool

The bear market in 2022 has provided opportunities to buy solid companies at a discount. Fears about a recession and rising interest rates have punished equities.

3 Beaten-Down Dividend Growers for Income Investors

Essex Property Trust

MDU Resources Group

National Retail Properties

Nu Skin Enterprises

Old Republic International

Bank OZK

South Jersey Industries

Telephone and Data Systems

United Bankshares

High Yield Dividend (HYD) Aristocrats from the S&P 1500 Composite Index have raised their annual payouts every year for at least 20 consecutive years. The 119 HYD Aristocrats screened as of July 26, 2022 represented all eleven Morningstar Sectors. Broker targeted-top-ten net-gainers ranged 15.2%-48.91% topped by VFC & TDS.

9 July Buys From 119 S&P 1500 High Yield Aristocrats

AGNC Investment

New York Community Bancorp

Omega Healthcare Investors

PIMCO Corporate & Income Opportunity Fund

Global X NASDAQ 100 Covered Call ETF

Global X Russell 2000 Covered Call ETF

Starwood Property

AT&T

Verizon

After 73 weeks and $7,300 allocated, the Dividend Harvesting portfolio is generating $512.73 in annual dividend income. The Dividend Harvesting portfolio has an 89.04% record of finishing the week in the black since its inception, 65/73 weeks.

Dividend Harvesting Week 73 Update: $7,300 Allocated, $512.73 In Annual Dividends Yielding 7.12% Across 78 Positions

The product – distributed nationwide to wholesale and retailer outlets such as CVS, Kroger, Walgreens, Harris Teeter, Rite Aid and Walmart – is used for relief of occasional constipation.

Laxatives sold at CVS, Walgreens recalled due to contamination

Boyd Gaming

Kohl's

Nexstar Media Group

Paramount Global

Warner Bros Discovery Inc

Even as uncertainty still puts pressure on the market, it may be a good time to take a look at these seven oversold value stocks. The post 7 Oversold Value Stocks to Buy Now appeared first on InvestorPlace.

7 Oversold Value Stocks to Buy Now

Walgreens Boots Alliance is moving toward becoming a customer-first organization that places a priority on interactions by using data and insights to make improvements.

Walgreens Boots Alliance: Using data and insights to transform the customer experience

Walgreens Boots Alliance is dealing with a fall in vaccinations with tough YoY comps. With stable revenues from the pharmacy business even in a macro situation and pent-up demand in other areas, there are some positives.

What Is Walgreens Stock's Outlook After Recent Earnings? Positive

Apple

Boeing

General Electric

Microsoft

Walmart

Track the latest stock market news from the Dow Jones today. Plus, get ongoing analysis of the 30 Dow stocks, including Apple, Boeing, Microsoft, Wal-Mart and GE.

Dow Jones Today: Dow Stocks And Stock Market News

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is teaming up with CAMP, the Family Experience Company, to bring the beach and summer fun to families across the U.S. before the back-to-school season begins. The collaboration seeks to educate kids about the importance of sun safety with a series of fun activities and a day of family play. Through free, limited edition Ultimate Beach Day Bundles, which can be reserved here and picked up at any of CAMP's nine retail locations starting August 5th, fami

This Way to the Beach: Walgreens and CAMP Collaborate to Create the Ultimate Beach Day Experience for Families

The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and WBA are likely to gain the most.

2 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges

The price is right, but Buffett might not bite.

Is Walgreens a Warren Buffett Stock?

Universal Corp

Drip Investing lists over 800 stocks that have annually increased dividends for 5 years or more. As of July, 62 stocks have hiked their dividends annually 40 years or more. Parsed from 129 Champions, utilizing YCharts data as of 7/14/22, those 62 select-dividend stocks ranged 0.86% to 5.89% in annual yield, and ranged -5.48% to 48.10% in analyst one-year price.

Seven 40-Year-Plus Dividend Growers To Buy In July

News for Walgreens Stock (WBA)